A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 150 KRW 2.84% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ABL Bio Inc
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Common Shares Outstanding
â‚©48m
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Common Shares Outstanding
â‚©207.2m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
5%
SK Bioscience Co Ltd
KRX:302440
Common Shares Outstanding
â‚©76.8m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Common Shares Outstanding
â‚©11m
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Common Shares Outstanding
â‚©10.3m
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Common Shares Outstanding
â‚©53.1m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Common Shares Outstanding?
Common Shares Outstanding
48m KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Common Shares Outstanding amounts to 48m KRW.

What is ABL Bio Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
4%

Over the last year, the Common Shares Outstanding growth was 1%. The average annual Common Shares Outstanding growth rates for ABL Bio Inc have been 1% over the past three years , 4% over the past five years .

Back to Top